Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVI-LM001 in Hypercholesterolemia
NCT04438096Phase 2Unknown
- Sponsor
- CVI Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LM-001 in hypercholesterolemia, sponsored by CVI Pharmaceuticals. Status: unknown.
02
Drugs
LM-001
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04438096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438096.